TELA Bio

TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a leader in the development of medical devices for soft tissue reconstruction, has made a significant stride in surgical innovation with the …

TELA Bio Introduces Revolutionary Hernia Mesh Fixation Devices in the U.S., Aiming to Transform Surgical Practices Read More

Ocugen

Ocugen, Inc. Welcomes Dr. Huma Qamar as New Chief Medical Officer to Spearhead Clinical Developments

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies, recently announced the appointment of Dr. Huma Qamar as its Chief Medical …

Ocugen, Inc. Welcomes Dr. Huma Qamar as New Chief Medical Officer to Spearhead Clinical Developments Read More

Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More
Neuronetics, Inc

Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading name in the field of non-invasive treatments for mental health conditions, has announced a significant expansion of its commercial partnership with …

Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment Read More